INTERINDIVIDUAL VARIABILITY OF ORGANIC CATION TRANSPORTER OCT1 (SLC22A1) AND OCT3 (SLC22A3) EXPRESSION IN HUMAN LIVER

被引：0
|
作者：
Nies, Anne T. [1 ]
Schaeffeler, Elke [1 ]
Klein, Kathrin [1 ]
Zanger, Ulrich M. [1 ]
Kerb, Reinhold [1 ]
Koepsell, Hermann [2 ]
Keppler, Dietrich [3 ]
Schwab, Matthias [1 ]
机构：
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany
[3] Deutsch Krebsforschungszentrum, Div Tumor Biochem, D-69120 Heidelberg, Germany
来源：
DRUG METABOLISM REVIEWS | 2008年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
215
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [41] Analysis of the gene structure of the human (SLC22A3) and murine (Slc22a3) extraneuronal monoamine transporter
    A. Wieland
    M. Hayer-Zillgen
    H. Bönisch
    M. Brüss
    [J]. Journal of Neural Transmission, 2000, 107 : 1149 - 1157
  • [42] Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
    Yang, Jian
    Kalogerou, Maria
    Gallacher, John
    Sampson, Julian R.
    Shen, Ming Hong
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1479 - 1490
  • [43] Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-α and -γ
    Nie, WX
    Sweetser, S
    Rinella, M
    Green, RM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (02): : G207 - G212
  • [44] SLC22A1/OCT1 Genotype Affects O-desmethyltramadol Exposure in Newborn Infants
    Matic, Maja
    de Wildt, Saskia N.
    Elens, Laure
    de Hoon, Jan N.
    Annaert, Pieter
    Tibboel, Dick
    van Schaik, Ron H. N.
    Allegaert, Karel
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 487 - 492
  • [45] ASSOCIATION OF VARIANTS OF SLC22A1 (OCT1) WITH THE RESPONSE TO IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Manuel, Perez-Encinas
    Angueira Francisco, Barros
    Jose, Rabunal Martinez M.
    Redondo Carlos, Ulibarrena
    Varela Nicolas, Diaz
    Garcia Celsa, Quinteiro
    Martinez Teresa, Gonzalez
    Perez Sonia, Gonzalez
    Vence Natalia, Alonso
    Lopez Angeles, Bendana
    Arias Jose, Diaz
    Mendez Isabel, Abuin
    Blanco Aitor, Abuin
    Perez Laura, Bao
    Orgeira Adrian, Mosquera
    Jose Luis, Bello Lopez
    [J]. HAEMATOLOGICA, 2016, 101 : 178 - 178
  • [46] Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
    Fizalah Kawoosa
    Zafar A. Shah
    Shariq R. Masoodi
    Asif Amin
    Roohi Rasool
    Khalid M. Fazili
    Abid Hamid Dar
    Asif Lone
    Samir ul Bashir
    [J]. BMC Endocrine Disorders, 22
  • [47] Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
    Kawoosa, Fizalah
    Shah, Zafar A.
    Masoodi, Shariq R.
    Amin, Asif
    Rasool, Roohi
    Fazili, Khalid M.
    Dar, Abid Hamid
    Lone, Asif
    ul Bashir, Samir
    [J]. BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [48] Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation
    Vialou, V
    Amphoux, A
    Zwart, R
    Giros, B
    Gautron, S
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (11): : 2846 - 2851
  • [49] Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
    Al-Eitan, Laith N.
    Almomani, Basima A.
    Nassar, Ahmad M.
    Elsaqa, Barakat Z.
    Saadeh, Nesreen A.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2019, 9 (01):
  • [50] Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
    Yokoo, Sachiko
    Masuda, Satohiro
    Yonezawa, Atsushi
    Terada, Tomohiro
    Katsura, Toshiya
    Inui, Ken-ichi
    [J]. DRUG METABOLISM AND DISPOSITION, 2008, 36 (11) : 2299 - 2306
12345